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Approximately 30% of epileptic patients worldwide are medically unable to control
their seizures. In addition, repeated epileptic seizures generally lead to neural damage.
Pentylenetetrazol (PTZ) is a clinical circulatory and respiratory stimulant that is
experimentally used to mimic epileptic convulsion in epilepsy research. Here, we
systematically explore the neuroprotective effects of a pure compound isolated from
Cynanchum otophyllum Schneid (Qingyangshen), Otophylloside N (OtoN), against PTZ-
induced neuronal injury. We used three models: in vitro primary cortical neurons, in vivo
mice, and in vivo zebrafish. Our results revealed that OtoN treatment may attenuate
PTZ-induced morphology changes, cell death, LDH efflux in embryonic neuronal cells
of C57BL/6J mice, and convulsive behavior in zebrafish. Additionally, our Western blot
and RT-PCR results demonstrated that OtoN may attenuate PTZ-induced apoptosis
and neuronal activation in neuronal cells, mice, and zebrafish. OtoN may reduce PTZ-
induced cleavage of poly ADP-ribose polymerase and upregulation of the Bax/Bcl-2
ratio and decrease the expression level of c-Fos. This study is the first investigation of
the neuroprotective effects of OtoN, which might be developed as a novel antiepileptic
drug.
Keywords: epilepsy, pentylenetetrazol, otophylloside N, Cynanchum otophyllum Schneid, neuroprotective effect,
apoptosis
INTRODUCTION
Epilepsy consists of a diverse set of neurological conditions, and it is characterized predominantly
by repeated epileptic seizures (Fisher et al., 2005; Löscher et al., 2013; Khoshnoud et al., 2015).
Epileptic seizures are transient symptoms that result from excessive abnormal or synchronous
cortical nerve cell activities in the brain. Although over 15 third-generation antiepileptic drugs
(AEDs) have been introduced to treat epilepsy, approximate 30% of patients are still medically
unable to control their seizures (Löscher et al., 2013; Yu et al., 2015). Moreover, approximately
30–40% of all epileptic patients are still affected by substantial side effects and seizure resistance
to the currently available AEDs (Schmidt, 2002). On the one hand, many investigations have
demonstrated that repetitive and prolonged seizures generally lead to widespread neuronal death
(Sankar et al., 1998). Substantial neuronal death is first likely to appear in areas of high susceptibility
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such as the cortex and hippocampus before spreading widely to
other structures. On the other hand, seizure-induced neuronal
injury might promote epileptogenesis (Dingledine et al., 2014).
Owing to the rich source and enormous structural diversity,
natural compounds such as baicalin (de Carvalho et al., 2011;
Liu et al., 2012), ganoderma lucidum polysaccharides (Zhou
et al., 2015), saikosaponin (Yu et al., 2012), and berberine
(Zhu and Qian, 2006; Bhutada et al., 2010) have been
associated with increased concern in recent years. In particular,
the effective dosages, the potential mechanisms underlying
the anticonvulsant or antiepileptic effects and the structure-
activity relationships of some of these active components have
been systematically reviewed (Zhu et al., 2014). Cynanchum
otophyllum Schneid (Chinese name: Qingyangshen) is a widely
used herbal medicine to treat epilepsy, lumbar muscle strain, and
rheumatism in southwestern China. Modern pharmacological
studies have revealed that the total extract of Qingyangshen
exhibits remarkable antiepileptic effects (Guo and Kuang, 1996;
Li et al., 2006). However, the pure compound responsible
for its therapeutic effect still remains unclear, except for
otophylloside A and B, which were reported nearly 30 years
ago (Mu et al., 1986). Therefore, the discovery of novel
constituents from C. otophyllum that exhibit antiepileptic activity
and neuroprotective effects is very important for further
development and utilization of this potential medicinal plant
resource.
Pentylenetetrazol (PTZ) is a circulatory and respiratory
stimulant that is clinically used to treat respiratory depression
and acute circulatory failure caused by drug (e.g., narcotic)
poisoning. However, high dosages of PTZ may result
in convulsions, which share similar behavioral and are
pharmacological character with human absence seizures,
and this type of convulsive actions can strongly mimic epileptic
seizures. Therefore, PTZ has been experimentally subjected
as a model inducer in the exploration of AEDs (Vlainic´ and
Pericic´, 2009; Löscher et al., 2013). In this study, we evaluated
Otophylloside N (OtoN), a C21 steroidal glycoside isolated
from C. otophyllum, for its neuroprotective effects. We used
three models, including primary cortical neurons, mice and
zebrafish, to systematically investigate the protective effects of
OtoN against PTZ-induced neuronal injury both in vitro and
in vivo.
MATERIALS AND METHODS
Animal Ethics Statement and
Maintenance
The Animal Ethics Committee of the Institute of Chinese Medical
Sciences, University of Macau approved this study (Ethical NO.
ICMS-AEC-2015-20). All of the procedures performed on the
animals were carried out in strict accordance with the ethical
guidelines of Institute of Chinese Medical Sciences, University of
Macau.
C57BL/6J mice aged 8–10 weeks were housed in standard
cages (temperature: 21 ± 1◦C; humidity: 60 ± 5%) with free
access to food and water. The animal room was subjected to be
12-hour light/12-hour dark cycle (lights on at 08:00). All the mice
were euthanized by rapidly cervical dislocation.
We maintained wild-type zebrafish according to the standard
procedures described in the Zebrafish Handbook (Westerfield,
1995). The stocks were maintained at a temperature of 28.5± 1◦C
in a 14-hour light/10-hour dark cycle in embryo medium
(13.7 mM NaCl, 540 µM KCl, 25 µM Na2HPO4, 44 µM
KH2PO4, 300 µM CaCl2, 100 µM MgSO4, 420 µM NaHCO3,
pH 7.4). The zebrafish were euthanized with overdose of MS-
222 (3-Aminobenzoic acid ethyl ester methanesulfonate) after
locomotor behavioral monitoring.
Preparation of Primary Cortical Neurons
We obtained primary cortical neurons from E16 mice embryos.
Briefly, the cortical tissue was dissected from embryonic brain
tissue in ice-cold DMEM/F12 medium and digested in 0.05%
trypsin for 15 min at 37◦C. The cell density was adjusted to
5 × 105/mL. Next, the cells were planted in poly-L-lysine and
Laminin (Sigma–Aldrich, St. Louis, MO, USA) coated culturing
ware in neurobasal medium with 2% B-27 supplement, 0.5%
GlutaMAX-ITM supplement, and 1% penicillin-streptomycin
(Gibco, USA). The culture medium was half replaced every
3 days.
Drug Administration
Pentylenetetrazol was purchased from Sigma–Aldrich and
freshly prepared prior to use. OtoN was isolated from C.
otophyllum and identified by the Faculty of Life Science
FIGURE 1 | Chemical structure of Otophylloside N.
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and Technology, Kunming University of Science and
Technology (Kunming, China); its purity exceeded 98%
(Figure 1).
We cultured the primary cells for 7 days in vitro (DIV) prior
to treating them with isometric fresh medium, PTZ (30 mM), and
PTZ (30 mM)+ OtoN of different dosages.
The mice were injected intraperitoneally with phosphate
buffer solution (PBS), PTZ (30 mg/kg), and PTZ
(30 mg/kg) + OtoN of different dosages in corresponding
groups. These injections were conducted between 09:00 and
10:00 every morning and repeated for 7 days.
Zebrafish larvae at 6 days post fertilization (dpf) were
pretreated with fresh embryo medium with different dosages of
OtoN for 24 h and then moved into medium or 10 mM PTZ
diluted in medium.
Immunocytochemistry
The drug-treated neurons were fixed with 4% paraformaldehyde
(Sigma–Aldrich) at room temperature. After three washes
with PBS, the cells were permeabilized with blocking buffer
(0.3% Triton X-100, 3% BSA, and 10% goat serum in PBS).
The cells were then incubated with primary antibodies,
including anti-MAP2 antibody (Novex, San Diego, CA,
1:500) or anti-β-Tubulin antibody (Invitrogen, CA, 1:500)
and anti-GFAP antibody (Abcam, USA, 1:1000) at 4◦C
overnight, and followed with corresponding secondary
antibodies for 1 h at room temperature in the dark.
Finally, the cell nuclei were counterstained with 5 µg/ml
of DAPI (Sigma–Aldrich) for 15 min. The samples were
photographed using an InCell2000 Analyzer (GE Healthcare,
USA).
CCK-8 Assay
Cell Counting Kit reagents (Beyotime, Shanghai, China) were
added to the culturing medium (1:10) in each well of a 96-
well plate. After incubating the mixture for 4 h at 37◦C, the
absorbance was measured using a FlexStation III microplate
reader (Molecular Devices, USA) at a wavelength of 450 nm.
Lactate Dehydrogenase Activity
Assessment
LDH enzyme activity was assayed using a Cytotoxicity Detection
Kit (Roche Mannheim, Germany). 100 µL of the reaction
mixture of the kit was added to the treated neurons in a
96-well plate followed by incubation at 37◦C for 30 min in
a dark environment. The absorbance was determined using
a microplate reader (Molecular Devices) at a wavelength of
490 nm.
Western Blot Analysis
The cells were lysed in RIPA lysis buffer containing 1% protease
inhibitor cocktail and 1% phenylmethanesulfonyl fluoride. For
the in vivo study, the cerebral cortex tissues were gently dissected
from the drug-treated mice and homogenized to suspension,
and then followed the same lysis step as described above for
the cells. We determined the protein concentration of the
FIGURE 2 | Investigation of Pentylenetetrazol (PTZ)-induced toxicity in primary cortical neurons. (A) Immunofluorescence detection of primary neuronal
cells and bright field of the same area. Cells were stained with mouse anti-MAP2 antibody (green) and rabbit anti-GFAP antibody (red, detection of astrocytes). The
nuclei are stained with DAPI (blue). (B) Observation of morphological changes of neurons using a contrast microscope at 7 days in vitro (DIV). The cells were treated
with 0, 7.5, 15, 30, and 60 mM PTZ for 24 h at 7 DIV. (C) PTZ-induced cellular toxicity in neurons. Cell viability is presented as a percentage of control, and each
value represents the mean ± SD of three independent experiments. Bar: 100 µm.
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lysates using a BCATM Protein Assay Kit (Pierce, Rockford,
IL, USA). The proteins were separated using SDS-PAGE and
then transferred to polyvinylidene fluoride membranes, blocked
with 5% non-fat milk for 2 h at room temperature. The
immunoreactions were carried out using poly ADP-ribose
polymerase (PARP), Bax and Bcl-2 antibodies (Abcam, 1:1000),
and then the membranes were probed with the corresponding
secondary antibodies for 1 h at room temperature. Specific
protein bands were visualized using the ECL Select Western
Blotting Detection Reagent (GE Healthcare, Buckinghamshire,
UK). Equal protein loading was verified by probing with anti-
GAPDH antibodies.
Locomotor Behavioral Monitoring of
Zebrafish
The zebrafish larvae were placed individually into 96-well
microplates with 12 larvae in each group and habituated to
their new environment for 30 min. The larvae were then treated
with embryo medium or 10 mM PTZ in each well. After
being pretreated with the indicated compound for 15 min in
an incubator (28.5 ± 1◦C), the plates were housed inside the
Zebrabox and monitored using a ZebraLab video tracking system
(Viewpoint Life Science, France). We recorded the swimming
behaviors of the larvae for 30 min. In the pre-experiments, we
defined three different velocity ranges: inaction (0–4 mm/s),
FIGURE 3 | Otophylloside N attenuated PTZ-induced cell injury on primary cortical neurons. The neurons were treated with indicated concentrations of PTZ
or PTZ + Otophylloside N (OtoN) for 24 h at 7 DIV. (A) Immunofluorescence detection of morphological changes of neurons and bright field of the same area. The
cells were immunostained with neuronal anti-β-Tubulin marker (green) and nuclear DAPI tag (blue). (B) OtoN inhibited PTZ-induced toxicity in neurons. Cell viability is
presented as a percentage of the control, and each value represents the mean ± SD of three independent experiments. (C) OtoN decreased PTZ-induced LDH
intracellular efflux in neurons. The LDH efflux level is presented as a percentage of the control, and each value represents the mean ± SD of three independent
experiments. ##P < 0.01 compared with the control. ∗∗P < 0.01 compared with the 30 mM PTZ treatment. Bar: 100 µm.
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small movement (4–20 mm/s), and large movement (above
20 mm/s).
Reverse Transcriptase-Polymerase
Chain Reaction
Approximately 55 zebrafish larvae at 7 dpf in each group were
homogenized for 5 min. Then, the total RNA was extracted
from the tissues using the RNeasy Plus Mini Kit (Qiagen,
Germany) in accordance with the manufacturer’s instructions.
The RNA concentration and purity were measured using
NanoVue Plus ROW (GE Healthcare). Then, the total RNA was
reverse-transcribed to single-strand cDNA using a PrimeScript
RT Reagent Kit (Perfect Real Time, Japan). Next, we carried
out quantitative real-time (RT) PCR on a ViiA 7 RT PCR
System (Life Technologies, Carlsbad, CA, USA) according to
the SYBR assay. The following primer sequences were selected
(Marques et al., 2008; Deng et al., 2009; Santos et al., 2014;
Vanhauwaert et al., 2014) : zebrafish β-actin, ACGATGGATG
GGAAGACA and AAATTGCCGCACTGGTT; zebrafish c-Fos,
TTACCCGCTCAACCAGACTC and TGACAGTTGGCACG
AAAGAG; zebrafish Bcl-2, TCACTCAGTTCAGACCCTCAT
and ACGCTTTCCACGCACAT; zebrafish Bax, TCACTCAGTT
CAGACCCTCAT and ACGCTTTCCACGCACAT. All of
the oligonucleotide primers were synthesized by Invitrogen.
Expressions of these genes were normalized to β-actin using the
relative quantification method.
Statistical Analysis
Data were expressed as mean ± standard deviation (SD). We
analyzed the statistical significances using one-way analysis of
variance (ANOVA) with the SPSS 17 software (Statistical Package
for the Social Sciences, Chicago, IL, USA). ∗/1P < 0.05 and
∗∗/11P < 0.01 were regarded as being statistically significant.
RESULTS
PTZ-Induced Neurotoxicity on Primary
Cortical Neurons
Qualifying the purity of neuronal cells is crucial for follow-
up research as well as for ensuring the reliability of the results
obtained. We first performed the qualification test. In the
immunocytochemistry studies, the cortical neurons were stained
with anti-MAP2 antibody (green) while the presence of astrocytes
was marked by anti-GFAP antibody (red). The nuclei were
counter stained with DAPI (blue). As shown in Figure 2A, no
astrocytes were found, which revealed that the purity of the
neuronal cells was high enough (>95%) for our research.
FIGURE 4 | Otophylloside N decreased PTZ-induced cell apoptosis and neuronal activation upon cortical neurons. The neurons were treated with
isometric fresh medium and the indicated concentrations of PTZ or PTZ + OtoN for 24 h at 7 DIV. (A) Protein levels of poly ADP-ribose polymerase (PARP), Bcl-2,
Bax, and c-Fos were determined by Western blot analysis. (B–D) The relative c-Fos, cleaved PARP, and Bax/Bcl-2 ratio were calculated. ##P < 0.01 compared with
controls. ∗P < 0.05 and ∗∗P < 0.01 compared with the 30 mM PTZ treatment.
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Pentylenetetrazol is a well-demonstrated chemical inducer
that mimics epileptic seizures. Exposure to PTZ (24 h) may result
in toxicity to neuronal cells, such as an altered morphology,
neurotransmission imbalance and cell death (Naseer et al., 2009).
As shown in Figure 2B, after treatment of PTZ at concentrations
of 7.5, 15, 30, and 60 mM, the cell morphologies were damaged
in a dose-dependent manner. The cell survival rates were reduced
to 83.06 ± 2.61, 55.69 ± 10.48, 30.68 ± 4.41, and 27.99 ± 3.91%,
respectively (Figure 2C). Compared with cells treated with 7.5
and 15 mM PTZ, the group treated with 30 mM PTZ exhibited
more visible injury and a lower cell survival rate. Moreover,
we noted that 30 mM PTZ maintained basic cellular shape and
yielded a similar survival rate of neurons as in the 60 mM
group. Therefore, 30 mM was selected as the dose for inducing
neurotoxicity in PTZ-treated neurons.
OtoN Attenuated PTZ-Induced Cell Injury
on Primary Cortical Neurons
In the previous screening of pure compounds from
C. otophyllum, we found that OtoN could remarkably improve
PTZ-induced neurotoxicity. β-Tubulin is a major component of
the eukaryotic cytoskeleton, and fluorescence images adequately
illustrate the cell morphology. In this study, we immunostained
the cells with neuronal β-Tubulin marker (green) and nuclear
DAPI tag (blue). As indicated in Figure 3A, the majority of
neurons in the PTZ group floated, and the existing cells were
adherent loosely and became shrinkage. Moreover, the synapses
of these cells were extremely injured as lysing in medium. OtoN
(5, 10 µg/mL)-involved groups exhibited more neuronal cells
that we preserved and denser maintained synapses than the PTZ
group.
We conducted CCK-8 assays to evaluate cell viability. After
drug administration, the two doses of OtoN attenuated PTZ-
induced cell death by increasing the cell survival rates from
32.45 ± 5.53 to 54.41 ± 8.42 and 66.26 ± 7.58%, respectively
(Figure 3B). In addition, leakage of LDH is a well-demonstrated
sign of injury on cellular membrane (Mohamed et al., 2014),
and our results revealed that the involvement of OtoN (5,
10 µg/mL) obviously decreased the intracellular LDH eﬄux level
(1.86 ± 0.04, 1.53 ± 0.05 fold) caused by PTZ (3.30 ± 0.07 fold)
(Figure 3C).
OtoN Decreased PTZ-Induced Cell
Apoptosis and Activation Upon Cortical
Neurons
Since apoptosis is a common cell-death pathway, we tested
the levels of several related proteins to verify whether PTZ
induced apoptosis as well as the protective effects of OtoN.
FIGURE 5 | Otophylloside N abated PTZ-induced cell apoptosis and neuronal activation in mouse cerebral cortex. The mice were injected
intraperitoneally with phosphate buffer solution (PBS), PTZ (30 mg/kg), and PTZ (30 mg/kg) + the indicated concentrations of OtoN in corresponding groups. This
injection were conducted between 09:00 and 10:00 every morning and repeated for 7 days. (A) Protein levels of PARP, Bcl-2, Bax, and c-Fos were determined by
Western blot analysis. (B–D) We calculated the relative c-Fos, cleaved PARP, and Bax/Bcl-2 ratio. ##P < 0.01 compared with controls. ∗P < 0.05 and ∗∗P < 0.01
compared with the 30 mg/kg PTZ treatment.
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Western blot analysis of neuronal cells (Figure 4A) revealed that
PTZ obviously induced the upregulation of the PARP cleaved
fragment 3.10 ± 0.35 fold, indicating the induction of apoptosis.
Meanwhile, the Bax/Bcl-2 ratio, an indicator that is generally
regarded as determining the susceptibility of cells to the induced
apoptosis, was also upregulated 2.31 ± 0.30 fold after treatment
with PTZ. With OtoN exposure, the upregulation trends of
the two indicators were significantly decreased (Figures 4C,D),
indicating that OtoN decreased PTZ-induced cell apoptosis. c-
Fos has been reported to be involved in response to neuronal
activation. Our results revealed that c-Fos was also activated
during PTZ treatment and that OtoN may decrease PTZ-induced
cortical neuron activation (Figure 4B).
OtoN Abated PTZ-Induced Cell
Apoptosis and Neuronal Activation in
Mouse Cerebral Cortex
To confirm the results obtained from the primary neuronal cells,
we further detected the expression levels of the proteins noted
above in the mouse cerebral cortex in vivo. As shown in Figure 5,
PTZ obviously induced the upregulation of PARP cleavage and
Bax/Bcl-2 ratio, indicating the induction of apoptosis in the
mouse cerebral cortex. Similarly, OtoN at concentrations of 2.5
and 5 µg/mL obviously abated PTZ-induced upregulation of
PARP cleavage and decreased the Bax/Bcl-2 ratio (Figures 5C,D).
Meanwhile, PTZ-induced c-Fos production was also decreased
with co-treatment with OtoN (Figure 5B). These results are
consistent with the outcomes on neurons in vitro.
OtoN Reduced PTZ-Induced
Neurotoxicity in Zebrafish
In a locomotor assay, PTZ-treated zebrafish exhibited high-
velocity epilepsy seizures that were significantly different from
those of the control group. In this case, we presented the results
according to large movements, which were visible as a red line
in the tracking images. As shown in Figure 6A, the activities
of the zebrafish in the PTZ group were significantly increased
compared to those of the control group, and the OtoN treatment
decreased the severe behaviors (the red line) on the contrary.
OtoN (12, 25 and 50 µg/mL) reduced the fast swimming distance
to 61.43 ± 10.09, 121.1 ± 13.65, 135.5 ± 22.36 mm from
222.2± 21.7 mm for the PTZ group (Figure 6B).
Beside behavior trial, we next tested gene expression in
zebrafish to confirm the prior results of apoptosis and activation.
According to the results of RT PCR, the PTZ model exhibited
an obvious increase (10.77 ± 1.24 fold) of c-Fos compared with
FIGURE 6 | Otophylloside N reduced PTZ-induced neurotoxicity in zebrafish. Zebrafish larvae 6 days after fertilization were pretreated with fresh embryo
medium and the indicated concentrations of OtoN for 24 h and then changed into fresh medium or 10 mM PTZ diluted in the medium. (A) Tracking lines of 30-minute
locomotor behaviors of individual larva. The three different colored lines represent different velocity ranges (black = 0–4 mm/s; green = 4–20 mm/s; red = 20+
mm/s). (B) We calculated the swimming distances of each group. Each value represents the mean ± SD of three independent experiments. (C–E) The relative
c-Fos, Bcl-2 gene expression levels, and Bax/Bcl-2 ratio was calculated. ##P < 0.01 compared with controls. ∗∗P < 0.01 compared with the 30 mM PTZ treatment.
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the control group (Figure 6C). OtoN (12, 25 and 50 µg/mL)
pretreatment downregulated the elevated c-Fos expression
(4.22 ± 0.07, 4.01 ± 0.71, and 3.48 ± 0.63 fold, respectively).
In terms of the apoptotic aspect, the ratio of Bax/Bcl-2 was
also significantly reduced by OtoN from 7.75 ± 0.45 fold in
the PTZ group to 3.20 ± 0.56, 2.67 ± 0.70, and 2.86 ± 0.26
fold at concentrations of 12, 25 and 50 µg/mL, respectively
(Figures 6D,E).
DISCUSSION
Although there are long-standing controversies whether epileptic
seizures lead to neuronal death, evidence has accumulated that
seizures that last for a long time and occur repeatedly over a
prolonged period induce neuronal death both experimentally and
clinically (Liu et al., 1999; Dingledine et al., 2014; Luo et al., 2015;
Naziroglu and Ovey, 2015). In this study, PTZ treatment results
were consistent with this theory based on data obtained from
embryonic neuronal cells, mouse cerebral cortex and zebrafish.
PTZ exposure indeed increased cell death and reduced cell
viability and neurite density. To date, studies on the antiepileptic
effect of OtoN and its analogs are extremely limited. The only
one report mainly focused on the structure analysis and indicated
that otophylloside A and B could protect rats from audiogenic
seizures. Thus further activities and mechanisms still remain to
be explored (Mu et al., 1986).
β-Tubulin is a major microtubule element and crucial
constituent of the neuronal cytoskeleton for maintaining cellular
shape, surface charges and intracellular transport (Zhou and
Giannakakou, 2005). Evidence has shown that even subtle
changes in microtubule dynamics can impair chromosome
attachment and kinetochore tension and eventually cause
aberrant mitosis and cell death (Karki et al., 2013). OtoN
interference preserves neuronal structure intact from PTZ
toxicity in certain extent. It has been suggested that OtoN
attenuates PTZ-induced neuronal injury by possibly avoiding
damage to the cellular framework.
Since PARP is a substrate of caspases, the amount of cleaved
PARP is a hallmark used to assess the propensity of cells to
apoptosis. Meanwhile, apoptosis is regulated by several signaling
pathways in which Bcl-2 protein families play key roles. Bcl-2 is
an anti-apoptotic protein that acts by inhibiting apoptotic cell
death, and Bax is a homolog of Bcl-2 that promotes apoptosis
(Giordano et al., 2008; Sanchez et al., 2012). The Bax/Bcl-2
ratio has been shown to determine the susceptibility of cells to
apoptosis. We found that OtoN treatment may protect neurons
from PTZ-induced toxicity, reverse PTZ-evoked cleavage of
PARP and decrease the Bax/Bcl-2 ratio. In another words, OtoN
contributes to preventing PTZ-induced neuronal injury partly
through inhibition of apoptosis pathway.
c-Fos is one of most commonly used cellular imaging among
the immediate-early gene family (Bengzon et al., 2002). Its
protein or mRNA products are generally used as markers
indicating neuronal activation given its rapid response to
stimulation (Sagar et al., 1988; Basheer et al., 1997; Cruz et al.,
2015). PTZ leads to obviously upregulated c-Fos expression on
proteins and genes. However, OtoN may decrease this trend.
These results indicated an overexciting state in cortical neurons,
mouse cerebral cortex and zebrafish treated with PTZ. As cellular
neuronal overexciting is the basis for neuronal injury, therefore, it
is reasonable to speculate that OtoN is capable of attenuate PTZ-
stimulated harmful neuronal activation partially via inhibition of
c-Fos activation.
Zebrafish have up to 80% homology with human genes,
and they are accordingly an ideal model organism for use
in genetics and developmental neurobiology studies (Leclercq
et al., 2015; Zhang et al., 2015). An effective zebrafish model in
accordance with conventional neurotoxicity assessments using
histological and behavioral studies has been established to reveal
promising neuroprotective drugs (Baraban et al., 2005). In our
zebrafish behavioral trials, it is notable that behavior changes were
completely recorded and then translated to figures by software,
which implies more objective findings than simply judging the
behavior changes visually. In the gene expression analysis, each
mRNA sample includes at least dozens of zebrafish. As a result,
the outcome itself in a certain sense reflects the overall trend
of the candidate drug on zebrafish. However, compared with
the cell-based in vitro study, OtoN has a more complex activity
profile in the mice and zebrafish models, which may be partially
due to various factors such as the complicated pharmacokinetic
dynamics of zebrafish and mice (Afrikanova et al., 2013). In the
case of the non-linear pharmacokinetics, further investigation
of the concentration-dependent kinetic of OtoN remains to be
conducted to help improve the dose design.
CONCLUSION
We have revealed the protective effect of OtoN on primary
embryonic neuronal cells. Its neuroprotective activity was further
confirmed using in vivo mouse and zebrafish models. These
results revealed that OtoN has a palpable protective effect on
chemical-induced neuronal disorders, and we suggest that OtoN
might be developed as a novel AED in the future.
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